S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Avoro Capital Advisors/Q4 2024

Avoro Capital Advisors

Periodo: Q4 2024 Β· Depositato: 2025-02-14
Vedi su SEC EDGAR β†—
AUM
$7.07B
Valore totale del portafoglio
Posizioni
39
Titoli dichiarati
Prima Posizione
UTHR
13.8% $973.9M
Var. Trimestrali
+7 / -4
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2025-02-14) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
UTHRUNITED THERAPEUTICS CORP$973.9M13.78%$352.84$555.91+57.5%
13.8%
ARGXARGENX SE$761.7M10.77%$615.00$939.68+52.8%
10.8%
ASNDASCENDIS PHARMA$702.5M9.94%$137.67$274.50+99.4%
9.9%
MDGLMADRIGAL PHARMACEUTICALS INC$626.1M8.86%$308.57$528.10+71.1%
8.9%
KRYSKRYSTAL BIOTECH INC$411.8M5.83%$156.66$375.07+139.4%
5.8%
APLSAPELLIS PHARMACEUTICALS INC.$390.0M5.52%$31.91β€”
5.5%
SRPTSAREPTA THERAPEUTICS INC$310.7M4.40%$121.59$19.28-84.1%
4.4%
ITCIINTRA-CELLULAR THERAPIES INC$254.7M3.60%β€”β€”
3.6%
VERAVERA THERAPEUTICS INC$237.3M3.36%$42.29$41.20-2.6%
3.4%
XENEXENON PHARMACEUTICALS INC$222.1M3.14%$39.20$60.96+55.5%
3.1%
FOLDAMICUS THERAPEUTICS INC.$218.3M3.09%β€”β€”
3.1%
RNAMAVIDITY BIOSCIENCES INC$218.1M3.08%β€”β€”
3.1%
ARWRARROWHEAD PHARMACEUTICALS INC.$208.9M2.95%$18.80$83.99+346.8%
3.0%
KYMRKYMERA THERAPEUTICS INC$207.2M2.93%$40.23$113.51+182.2%
2.9%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$150.0M2.12%$54.15$18.95-65.0%
2.1%
SLNOSOLENO THERAPEUTICS INC$113.5M1.61%$44.95β€”
1.6%
BPMCBLUEPRINT MEDICINES CORP$103.4M1.46%β€”β€”
1.5%
PCVXVAXCYTE INC$96.2M1.36%$81.86$58.39-28.7%
1.4%
BMRNBIOMARIN PHARMACEUTICAL INC$96.1M1.36%$65.73$58.99-10.3%
1.4%
MRUSMERUS N V$89.4M1.26%β€”β€”
1.3%
BCRXBIOCRYST PHARMACEUTICALS INC$89.2M1.26%$7.52$9.84+30.9%
1.3%
ALKSALKERMES PLC$70.5M1.00%$28.76$54.58+89.8%
1.0%
OCULOCULAR THERAPEUTIX INC$68.8M0.97%$8.54$9.64+12.9%
1.0%
MNKDMANNKIND CORP$56.3M0.80%$6.43$4.52-29.7%
0.8%
TRMLTOURMALINE BIO INC$45.1M0.64%β€”β€”
0.6%
QUREUNIQURE NV$38.4M0.54%$17.66$41.81+136.8%
0.5%
RAREULTRAGENYX PHARMACEUTICAL INC$34.9M0.49%$42.07$33.47-20.4%
0.5%
TSHATAYSHA GENE THERAPIES INC$34.6M0.49%$1.73$6.53+277.5%
0.5%
ETNB89BIO INC$32.1M0.45%β€”β€”
0.5%
GLUEMONTE ROSA THERAPEUTICS INC$30.1M0.43%$6.94$24.21+248.8%
0.4%

AttivitΓ  Trimestre su Trimestre

Q4 2024 vs. Q3 2024

Nuove Posizioni (7)

TickerEmittenteNozionaleDal Deposito
BPMCBLUEPRINT MEDICINES CORP$103.4M
ALKSALKERMES PLC$70.5M+89.8%
QUREUNIQURE NV$38.4M+136.8%
ETNB89BIO INC$32.1M
SEPNSEPTERNA INC$25.4M
RCKTROCKET PHARMACEUTICALS INC$15.1M
OLMAOLEMA PHARMACEUTICALS INC$9.6M

Posizioni Chiuse (4)

TickerEmittenteNozionale
DYNDYNE THERAPEUTICS INC.$23.4M
SYRESPYRE THERAPEUTICS INC$17.6M
NGNENEUROGENE INC$0.9M
INSMED INC$0.1M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
MRUSMERUS N V$21.7M+56.8%
VERAVERA THERAPEUTICS INC$46.8M+30.2%-2.6%
ARWRARROWHEAD PHARMACEUTICALS INC.$36.7M+25.0%+346.8%
SLNOSOLENO THERAPEUTICS INC$3.4M+15.8%
KYMRKYMERA THERAPEUTICS INC$-5.8M+14.4%+182.2%
APLSAPELLIS PHARMACEUTICALS INC.$69.6M+10.0%
RNAMAVIDITY BIOSCIENCES INC$-97.7M+9.1%
TSHATAYSHA GENE THERAPIES INC$-2.9M+7.2%+277.5%

Ridotte (7)

TickerEmittenteNozionaleVar. AzioniDal Deposito
SNDXSYNDAX PHARMACEUTICALS INC$-44.8M-41.5%
KURAKURA ONCOLOGY INC$-49.6M-36.5%
BMRNBIOMARIN PHARMACEUTICAL INC$-47.1M-28.2%-10.3%
GLUEMONTE ROSA THERAPEUTICS INC$-0.5M-25.0%+248.8%
AUTLAUTOLUS THERAPEUTICS PLC$-21.5M-19.7%
IOVAIOVANCE BIOTHERAPEUTICS INC$-13.9M-17.5%
UTHRUNITED THERAPEUTICS CORP$-50.5M-3.4%+57.5%
← Torna agli Hedge Fund